Saturday May 4, 2024 | Last Update: May 4, 2024 EDT
A new experimental class of drugs aimed at lowering cholesterol has proven to be most effective protection against cardiovascular disease since the introduction of statins. The studies were presented at the American College of Cardiology conference in Washington on Saturday.
Read more >>
Merck is pulling back its Liptruzet product because of packaging problems that might hinder its power.
Just In
Most Read
1
2
3
4
5